Naoxintong/PPAR<svg xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/2000/svg" style="vertical-align:-4.26851pt" id="M1" height="12.2747pt" version="1.1" viewBox="-0.0657574 -8.00619 9.07093 12.2747" width="9.07093pt"><g transform="matrix(.017,0,0,-0.017,0,0)"><path id="g5-225" d="M498 369C498 423 469 454 440 454C415 454 388 432 388 408C388 398 391 390 395 384C401 375 413 354 413 330C413 269 332 132 280 70H278C285 133 286 231 273 319C259 412 231 454 191 454C147 454 85 416 21 322L49 293C91 339 110 351 119 351C129 351 132 349 142 324C181 225 194 56 178 -19C148 -80 115 -167 107 -224L125 -246C167 -243 241 -219 265 -202C260 -169 255 -95 256 -21C261 -11 268 2 323 70C438 212 498 291 498 369Z"/></g></svg> Signaling Inhibits Cardiac Hypertrophy via Activation of Autophagy

Yuan, Shuping; Jin, Jianhua; Chen, Lu; Hou, Yongzhong; Wang, Hong

doi:https://doi.org/10.1155/2017/3801976

Evidence-Based Complementary and Alternative Medicine

On this page

Abstract Introduction Materials and Methods Results Conclusion Acknowledgments References Copyright Related Articles

Research Article | Open Access

Volume 2017 | Article ID 3801976 | https://doi.org/10.1155/2017/3801976

Naoxintong/PPAR Signaling Inhibits Cardiac Hypertrophy via Activation of Autophagy

Shuping Yuan,¹Jianhua Jin,²Lu Chen,^3,4Yongzhong Hou ,¹and Hong Wang^3,4,5

Academic Editor: Kuzhuvelil B. Harikumar

Received16 Aug 2016

Accepted01 Dec 2016

Published15 Feb 2017

Abstract

As a traditional Chinese medicine, Naoxintong capsule (NXT) has been approved by China Food and Drug Administration (CFDA), which is used for cardiocerebrovascular disease treatment. Here we found that NXT extract significantly promoted H9c2 cardiomyocyte cell autophagy involved in increased autophagy-associated gene expression leading to inhibition of mTOR signaling. Moreover, NXT extract increased PPARγ protein expression and transcription activity of H9c2 cell. Consistent with this, in PPARγ gene silenced H9c2 cells, NXT had no effect on autophagy and mTOR signaling. Furthermore, NXT/PPARγ-mediated H9c2 autophagy led to inhibition of cardiomyocyte cell hypertrophy. These findings suggest that the extract of NXT inhibited H9c2 cardiomyocyte cell hypertrophy via PPARγ-mediated cell autophagy.

1. Introduction

As a traditional Chinese medicine, Naoxintong capsule (NXT) has been approved by China Food and Drug Administration (CFDA, Z20025001), which is used for cardiocerebrovascular disease treatment [1, 2]. NXT is a formula that consists of sixteen traditional Chinese medicines: Radix Paeoniae (Chishao), Commiphora myrrha Eng1 (Moyao), Semen Persicae (Taoren), Radix paeoniae Rubra (Chishao), Radix Angelicae Sinensis (Danggui), Mulberry Twig (Sangzhi), Achyranthes bidentata (Niuxi), Rhizoma Ligustici Chuanxiong (Chuanxiong), Salviae miltiorrhizae radix et rhizoma (Danshen), Spatholobus stem (Jixueteng), Boswellia carteri (Ruxiang), Cassia Twig (Guizhi), Astragalus membranaceus (Fisch.) Bge. (Huangqi), and animal medicines: Scorpio (Quanxie), Pheretima (Dilong), and Hirudo nipponica Whitman (Shuizhi). Other reports show that NXT can decrease atherosclerosis associated with inhibition of dendritic cell maturation and iNOS expression [3, 4]. In addition, other clinical observations suggest that NXT can decrease subsequent MACE (major adverse cardiovascular events) [5]. Moreover, NXT ethanol extract decreases H2O2-mediated cardiomyocyte cell damage [6] and the development of diabetic retinopathy [7]; however, the effect of NXT on the cardiac hypertrophy is still unclear. Cardiac hypertrophy results from an increase in protein synthesis, cell size, and thickening of the heart muscle. Cardiac hypertrophy can cause heart failure and arrhythmia. However, activation of autophagy pathway can inhibit cardiac hypertrophy [8]. Autophagy delivers cytoplasmic materials or organelles into lysosomes for degradation, which is also a progress of nutrient recycling [9]. In addition, PPARs (peroxisome-proliferator-activated receptors) are the nuclear hormone receptor including PPARα, PPARδ, and PPARγ, which play a critical role in regulation of obesity, cardiovascular diseases, and inflammation [10–13]. Other report shows that PPARα regulate autophagy [14]. Here we found that NXT/PPARγ signaling inhibited H9c2 cardiomyocyte cell hypertrophy via autophagy.

2. Materials and Methods

2.1. Preparation of NXT Extract

Naoxintong capsule was obtained from Buchang Pharmaceutical Co., Ltd., China. NXT powder was incubated in 60°C H2O for 6 h and then centrifuged. The supernatant was filtered and freeze-dried.

2.2. Cell Culture and Treatment

H9c2 cells were cultured in DMEM supplemented with 10% fetal bovine serum (FBS, Gibco). Cells were treated with or without NXT water extraction as indicated time course.

2.3. Immunofluorescence

H9c2 cells were fixed for 15 min with 3.7% paraformaldehyde and washed with PBS. After that, cells were blocked with BSA for 1 h, and then cells were incubated with LC3b primary antibody and subsequently with secondary antibody (Jackson ImmunoResearch). Images were taken on a confocal microscope.

2.4. Luciferase Assay

H9c2 cells were transfected with PPRE3-luciferase reporter and Ptk-RL and PPARγ plasmids as indicated. After 24 h, cells were treated with or without 0.5 μg/mL NXT for 6 h. Cell lysates were assayed by using a Dual-Luciferase reporter assay system (Promega).

2.5. Cell Size Assay

After treatment with or without NXT, H9c2 cells were stained with Alexa Fluor 555 phalloidin. Immunostained cells were imaged on a fluorescence microscope. Cell surface area was quantified by using image software.

2.6. Real-Time PCR Analysis

Total RNA was isolated using RNeasy kit (Sangon Biotech) and assayed by using Real-Time PCR assay kit (Takara). mRNA expression was normalized against GAPDH. Fold change over control was determined according to the Ct method.

2.7. Western Blot

H9c2 cells were seeded in 6-well plates and cultured as mentioned above. Cells were lysed in lysis buffer containing protease inhibitors. Protein concentration in the supernatant was determined by the Pierce BCA Protein Assay Kit (Thermo). The samples were subjected to 10% SDS-PAGE, transferred to a nitrocellulose membrane, then probed by Western blot analysis with the indicated antibodies, and developed by using an ECL reagent. LC3-b antibody was purchased from Novus Biologicals. Other antibodies were purchased from Sangon Biotech.

2.8. Statistical Analysis

Data are expressed as mean ± SEM. Statistical comparison was carried out with Student’s -test or one-way analysis of variance (ANOVA).

3. Results

3.1. NXT Promotes H9c2 Cell Autophagy

Figure 1(a) shows that NXT promoted H9c2 cell autophagy in a time-dependent manner, and the LC3-II/LC3-I levels were markedly increased after NXT treatment cells for 6 h. Further analysis shows that NXT time-dependent decreased the p62/SQSTM1 protein levels (Figure 1(b)). Immunofluorescence analysis shows that NXT significantly increased H9c2 cell autophagosome accumulation (Figure 1(c)), which is consistent with the Western blot results (Figure 1(a)). Autophagy-associated gene levels play an important role in activation of autophagy signaling [14]. Real-Time PCR analysis shows that NXT significantly increased the autophagy-associated gene expressions including Atg16, LC3-a, LC3b, and ULK1 (Figure 1(d)). These findings show that NXT promoted H9c2 cardiomyocyte cell autophagy involved in increased autophagy-associated gene expressions.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

Figure 1

NXT promotes autophagy. (a) H9c2 cells were treated with 0.5 μg/mL NXT as indicated time course. Cell lysates were subjected to Western blot. (b) Quantitation of LC3-II/LC3-I levels was shown. Results are expressed as means ± SEM (). (c) H9c2 cells were treated with 0.5 μg/mL NXT as indicated time course. Cell lysates were subjected to Western blot. (d) Quantitation of p62/SQSTM1 levels was shown. Results are expressed as means ± SEM (). (e) H9c2 cells were treated with or without 0.5 μg/mL NXT for 3 h. Immunofluorescence analysis was performed. (f) Quantitation of LC3 puncta was shown. Results are expressed as means ± SEM (). (g) H9c2 cells were treated with or without 0.5 μg/mL NXT for 6 h. Autophagy-associated gene expression was assayed by qPCR. Results are expressed as means ± SEM ().

3.2. NXT Inhibits mTOR Signaling

TOR (target of rapamycin) plays a critical role in promoting cell survival, proliferation, and protein synthesis; in addition, activation of TOR signaling leads to autophagy inhibition [15]. Although our results show that NXT promoted autophagy, it is still unclear whether NXT inhibited mTOR signaling. Western blot analysis shows that NXT treatment H9c2 cells significantly inhibited phosphorylation of mTOR in a time-dependent manner (Figure 2). Activation of mTOR leads to downstream signaling 4EBP1 protein phosphorylation [15]. Further analysis shows that NXT inhibited 4EBP1 phosphorylation (Figure 2). These findings show that NXT inhibited mTOR signaling pathway, which contributes to cell autophagy.

3.3. NXT Increases PPARγ Expression

Activation of PPARs can increase autophagy [14]. Further analysis shows that NXT increased PPARγ protein levels (Figure 3(a)). To detect whether the expression of PPARγ could enhance its transcription activity, H9c2 cells were transfected with PPRE3-luciferase reporter together with PPARγ plasmids. The Dual-Luciferase assay shows that NXT significantly increased PPARγ activity. These findings show that NXT increased PPARγ protein levels resulting in enhancing PPARγ transcription activity.

(a)

(b)

3.4. NXT/PPARγ Signaling Promotes Autophagy

Our data have demonstrated that NXT promoted H9c2 cardiomyocyte cell autophagy involved in increased PPARγ expression. H9c2 cells were transfected with PPARγ shRNA to silence PPARγ expression. The results show that PPARγ silenced H9c2 cells had no effect on autophagy in response to NXT stimulus (Figure 4(a)). Further analysis shows that silenced PPARγ resulted in inhibition of p62/SQSTM1 degradation in response to NXT (Figure 4(b)). More importantly, silenced PPARγ did not increase autophagy-associated gene expression (Figure 4(c)). These findings show that NXT/PPARγ signaling increased autophagy-associated gene expression and autophagy.

(a)

(b)

(c)

Figure 4

NXT/PPARγ signaling mediates autophagy. (a) H9c2 cells were transfected with control shRNA or PPARγ shRNA plasmids. After 24 h, cells were treated with or without 0.5 μg/mL NXT for 3 h. Cell lysates were subjected to Western blot. Quantitation of LC3-II/LC3-I level was shown. Results are expressed as means ± SEM (). (b) H9c2 cells were transfected with control shRNA or PPARγ shRNA plasmids. After 24 h, cells were treated with or without 0.5 μg/mL NXT for 3 h. Cell lysates were subjected to Western blot. Quantitation of p62/SQATM1 level was shown. Results are expressed as means ± SEM (). (c) H9c2 cells were transfected with control shRNA or PPARγ shRNA plasmids. After 24 h, cells were treated with or without 0.5 μg/mL NXT for 6 h. Autophagy-associated gene expression was assayed by qPCR. Results are expressed as means ± SEM ().

3.5. NXT/PPARγ Signaling Inhibits mTOR Signaling

Activation of mTOR signaling leads to cell survival, proliferation, protein synthesis, and autophagy inhibition [15]. Our above data have demonstrated that NXT inhibited H9c2 cell mTOR signaling. We next detected whether silenced PPARγ could affect mTOR signaling in response to NXT. The results show that NXT had no effect on the phosphorylation of mTOR and 4EBP1 in PPARγ silenced H9c2 cells (Figure 5), suggesting that NXT/PPARγ inhibited mTOR signaling.

3.6. NXT/PPARγ Signaling Inhibits Cardiomyocyte Cell Hypertrophy

Cardiac hypertrophy results from increased in protein synthesis and cell size. Activation of mTOR signaling promotes protein synthesis [15]. Autophagy can degrade cytoplasmic misfolded protein leading to inhibition of cardiac hypertrophy [8, 9]. Our data demonstrated that NXT/PPARγ signaling inhibited autophagy and mTOR signaling. Further analysis shows that NXT inhibited H9c2 surface area by using Alexa Fluor 555 phalloidin staining (Figure 6(a)). Moreover, silenced PPARγ did not reduce H9c2 cell surface area in response to NXT treatment (Figure 6(b)). These findings suggest that NXT/PPARγ signaling decreased H9c2 cardiomyocyte cell hypertrophy.

(a)

(b)

Figure 6

NXT/PPARγ signaling inhibits cardiac hypertrophy. (a) H9c2 cells were treated with or without 0.5 μg/mL NXT for 6 h. Cells were stained with Alexa Fluor 555 phalloidin. Immunostained cells were imaged on a fluorescence microscope. Cell surface area was quantified. (b) H9c2 cells were transfected with control shRNA or PPARγ shRNA plasmids. After 24 h, cells were treated with or without 0.5 μg/mL NXT for 6 h. Cells were stained with Alexa Fluor 555 phalloidin. Immunostained cells were imaged on a fluorescence microscope. Cell surface area was quantified.

4. Discussions

As a traditional Chinese medicine, NXT has been approved by China Food and Drug Administration (CFDA). NXT is used for treatment of cardiocerebrovascular accident [1, 2, 16]. As the Chinese herbal compound, the chemical compositions were identified by UPLC/Q-TOF-MS [17]. In addition, NXT activates PI3K-Akt pathway resulting in inhibition of oxygen-glucose deprivation/reoxygenation-induced neurons damage [18]. The combination of NXT and dual antiplatelet therapy can reduce coronary microembolization [19]. NXT suppresses atherosclerosis of the mice model [4], which is involved in reduced expression of iNOS in the vessel wall [3]. Moreover, NXT alleviates the development of diabetic retinopathy [7]. Although the ethanol extraction of NXT reduces H9c2 cell damage [6], the mechanism of NXT on the cardiomyocyte cell hypertrophy is still unclear. Here we found that NXT water extract significantly promoted H9c2 cell autophagy and autophagy-associated gene expression. Autophagy is a conserved catabolic process by delivering cytoplasmic materials or organelles into lysosomes for degradation, which is also a progress of nutrient recycling [9]. Unlike ubiquitin-proteasome system (UPS) to degrade short-lived proteins, autophagy is a bulk degradation of long-lived proteins and organelles including mitochondria, endoplasmic reticulum, nucleus, and peroxisomes [9, 20]. Autophagy can degrade misfolded or damaged proteins to maintain cellular homeostasis [9]. Other reports show that autophagy mediated regression of cardiac hypertrophy [21, 22]. Consistent with this, our data show that NXT significantly inhibited H9c2 cardiomyocyte cell hypertrophy involved in promoting autophagy. Activation of mTOR signaling pathway leads to cardiomyocyte cell protein synthesis and hypertrophy [22]. NXT inhibited mTOR signaling activation, which is benefit of inhibition of H9c2 cell hypertrophy. Although our data have demonstrated that NXT inhibited H9c2 cell hypertrophy via autophagy, the mechanism is still unclear. Peroxisome-proliferator-activated receptors (PPARs) are the nuclear hormone receptor including PPARα, PPARδ, and PPARγ, which play a critical role in regulation of obesity, cardiovascular diseases, and inflammation [10–13]. Another report shows that PPARα regulates autophagy [14]. Further analysis shows that NXT increased PPARγ expression and transcription activity. Silenced PPARγ inhibited NXT-mediated H9c2 cell autophagy and autophagy-associated gene expression. Consistent with this, silenced PPARγ alleviated the inhibition of H9c2 cell hypertrophy in response to NXT. In addition, p62/SQSTM1 protein is autophagy cargo, which targets ubiquitinated misfolded protein for lysosome degradation to maintain cellular homeostasis [9]. Therefore, NXT/PPARγ signaling-mediated p62/SQSTM1 degradation may be of benefit to inhibition of cardiomyocyte cell hypertrophy.

5. Conclusion

These findings suggest that NXT/PPARγ signaling inhibited H9c2 cardiomyocyte cell hypertrophy via autophagy.

Competing Interests

The authors declare that they have no competing interests.

Acknowledgments

The authors acknowledge the financial support from the project supported by the National Natural Science Foundation of China (81173592), the Program for Changjiang Scholars and Innovative Research Team in University, PCSIRT (IRT1276), Program of International S&T Cooperation Project of China (2015DFA30430), Program for New Century Excellent Talents in University of Ministry of Education of China (NCET-13-0935), and Natural Science Foundation of Tianjin Municipal Government (16JCZDJC36300).

References

L. Su, Y. Li, B. Lv et al., “Clinical study on Naoxintong capsule for stroke recovery of Qi-deficiency and blood-stasis syndrome,” Zhongguo Zhong Yao Za Zhi, vol. 36, no. 11, pp. 1530–1533, 2011.
View at: Publisher Site | Google Scholar
S.-R. Li, T.-H. Wang, and B.-J. Zhang, “[Effects of naoxintong capsule on the inflammation and prognosis in borderline lesion coronary heart disease patients],” Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine / Zhongguo Zhong xi yi jie he xue hui, Zhongguo Zhong yi yan jiu yuan zhu ban, vol. 32, no. 5, pp. 607–611, 2012.
View at: Google Scholar
X.-N. Zhong, H.-H. Wang, Z.-Q. Lu et al., “Effects of naoxintong on atherosclerosis and inducible nitric oxide synthase expression in atherosclerotic rabbit,” Chinese Medical Journal, vol. 126, no. 6, pp. 1166–1170, 2013.
View at: Publisher Site | Google Scholar
J. Zhao, H. Zhu, S. Wang et al., “Naoxintong protects against atherosclerosis through lipid-lowering and inhibiting maturation of dendritic cells in LDL receptor knockout mice fed a high-fat diet,” Current Pharmaceutical Design, vol. 19, no. 33, pp. 5891–5896, 2013.
View at: Publisher Site | Google Scholar
H. Xu, M. You, H. Shi, and Y. Hou, “Ubiquitin-mediated NFκB degradation pathway,” Cellular and Molecular Immunology, vol. 12, no. 6, pp. 653–655, 2015.
View at: Publisher Site | Google Scholar
F. Zhang, B. Huang, Y. Zhao et al., “BNC protects H9c2 cardiomyoblasts from H₂O₂-induced oxidative injury through ERK1/2 signaling pathway,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 802784, 12 pages, 2013.
View at: Publisher Site | Google Scholar
S. Grivennikov, E. Karin, J. Terzic et al., “IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer,” Cancer Cell, vol. 15, no. 2, pp. 103–113, 2009.
View at: Publisher Site | Google Scholar
A. Nakai, O. Yamaguchi, T. Takeda et al., “The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress,” Nature Medicine, vol. 13, no. 5, pp. 619–624, 2007.
View at: Publisher Site | Google Scholar
J. Kaur and J. Debnath, “Autophagy at the crossroads of catabolism and anabolism,” Nature Reviews Molecular Cell Biology, vol. 16, no. 8, pp. 461–472, 2015.
View at: Publisher Site | Google Scholar
L. Michalik, B. Desvergne, and W. Wahli, “Peroxisome-proliferator-activated receptors and cancers: complex stories,” Nature Reviews Cancer, vol. 4, no. 1, pp. 61–70, 2004.
View at: Publisher Site | Google Scholar
Y. Hou, F. Moreau, and K. Chadee, “PPARγ is an E3 ligase that induces the degradation of NFκB/p65,” Nature Communications, vol. 3, article 1300, 2012.
View at: Publisher Site | Google Scholar
Y. Hou, J. Gao, H. Xu et al., “PPARγ E3 ubiquitin ligase regulates MUC1-C oncoprotein stability,” Oncogene, 2013.
View at: Publisher Site | Google Scholar
Z. Zhang, Y. Xu, Q. Xu, and Y. Hou, “PPARγ against tumors by different signaling pathways,” Onkologie, vol. 36, no. 10, pp. 598–601, 2013.
View at: Publisher Site | Google Scholar
J. M. Lee, M. Wagner, R. Xiao et al., “Nutrient-sensing nuclear receptors coordinate autophagy,” Nature, vol. 516, no. 7529, pp. 112–115, 2014.
View at: Publisher Site | Google Scholar
C. H. Jung, S.-H. Ro, J. Cao, N. M. Otto, and D.-H. Kim, “mTOR regulation of autophagy,” FEBS Letters, vol. 584, no. 7, pp. 1287–1295, 2010.
View at: Publisher Site | Google Scholar
H. Xu, J. Jin, L. Chen et al., “Naoxintong/PPARα signaling inhibits H9c2 cell apoptosis and autophagy in response to oxidative stress,” Evidence-Based Complementary and Alternative Medicine, vol. 2016, Article ID 4370381, 10 pages, 2016.
View at: Publisher Site | Google Scholar
X. Ma, B. Lv, P. Li et al., “Identification of ‘multiple components-multiple targets-multiple pathways’ associated with naoxintong capsule in the treatment of heart diseases using UPLC/Q-TOF-MS and network pharmacology,” Evidence-Based Complementary and Alternative Medicine, vol. 2016, Article ID 9468087, 15 pages, 2016.
View at: Publisher Site | Google Scholar
Y. Ma, P. Zhao, J. Zhu et al., “Naoxintong Protects primary neurons from oxygen-glucose deprivation/reoxygenation induced injury through PI3K-Akt signaling pathway,” Evidence-based Complementary and Alternative Medicine, vol. 2016, Article ID 5815946, 12 pages, 2016.
View at: Publisher Site | Google Scholar
M.-W. Huang, H. Wang, W.-J. Zhong, X.-Y. Wu, and H. Chen, “Chinese herbal medicine Naoxintong capsule combined with dual antiplatelet therapy in a rat model of coronary microembolization induced by homologous microthrombi,” Journal of Chinese Integrative Medicine, vol. 9, no. 1, pp. 38–48, 2011.
View at: Publisher Site | Google Scholar
N. Mizushima and D. J. Klionsky, “Protein turnover via autophagy: implications for metabolism,” Annual Review of Nutrition, vol. 27, pp. 19–40, 2007.
View at: Publisher Site | Google Scholar
N. Hariharan, Y. Ikeda, C. Hong et al., “Autophagy plays an essential role in mediating regression of hypertrophy during unloading of the heart,” PLOS ONE, vol. 8, no. 1, Article ID e51632, 2013.
View at: Publisher Site | Google Scholar
Y. Li, C. Chen, F. Yao et al., “AMPK inhibits cardiac hypertrophy by promoting autophagy via mTORC1,” Archives of Biochemistry and Biophysics, vol. 558, pp. 79–86, 2014.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2017 Shuping Yuan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

1079

Downloads

851

Citations